Xanthone Derivatives in the Fight against Glioblastoma and Other Cancers
Source abstract
Abstract
Xanthone derivatives constitute an interesting and widely studied group of compounds, both in terms of the activity of naturally occurring plant ingredients and as a scaffold with high biological activity potential for medicinal chemists. This group of compounds has already been the subject of reviews. However, our purpose was to prepare a publication for medicinal chemists to have a clear overview of anticancer activity, particularly in central nervous system cancer glioblastoma, and to be able to compare their new achievements to the anticancer activity that has already been found in this group. An integral part of the work is a tabular summary of the literature results of antineoplastic activity (e.g., IC50 values) for xanthone derivatives in various types of in vitro viability assays.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Natural Compound Pharmacology Studies · Bioactive Compounds and Antitumor Agents · Phytochemistry and biological activity of medicinal plants
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioorganic Chemistry, Chair of Organic Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland
Funding
Jagiellonian University Medical College
References (74)
Show source-provided references
1. Mazimba, O., Nana, F., Kuete, V., and Singh, G.S. (2013). Xanthones and Anthranoids from the Medicinal Plants of Africa, Elsevier.10.1016/B978-0-12-405927-6.00011-4 ↗
2. Pinto, M.M.M., Palmeira, A., Fernandes, C., Resende, D.I.S.P., Sousa, E., Cidade, H., Tiritan, M.E., Correia-Da-silva, M., and Cravo, S. (2021). From Natural Products to New Synthetic Small Molecules: A Journey through the World of Xanthones. Molecules, 26.10.3390/molecules26020431 ↗
3. Xanthones and Cancer: From Natural Sources to Mechanisms of Action10.1002/cbdv.201900499 ↗
4. Synthesis and in Vitro Evaluation of Anticancer Potential of New Aminoalkanol Derivatives of Xanthone10.2174/1871520616666160404110323 ↗
5. Contribution of Reactive Oxygen Species to the Anticancer Activity of Aminoalkanol Derivatives of Xanthone10.1007/s10637-017-0537-x ↗
6. Rech, J., Sypniewski, D., Żelaszczyk, D., Szkaradek, N., Rogóż, W., Waszkielewicz, A., Marona, H., and Bednarek, I. (2021). Novel Xanthone Derivatives Impair Growth and Invasiveness of Colon Cancer Cells in Vitro. Biomolecules, 11.10.3390/biom11101480 ↗
7. Anticonvulsant Activity of Some Xanthone Derivatives10.1016/j.bmc.2008.06.039 ↗
8. Synthesis and Evaluation of Pharmacological Properties of Some New Xanthone Derivatives with Piperazine Moiety10.1016/j.bmcl.2013.05.062 ↗
9. Xanthone Suppresses Allergic Contact Dermatitis in Vitro and in Vivo10.1016/j.intimp.2019.106061 ↗
10. A Comprehensive Review on Xanthone Derivatives as α-Glucosidase Inhibitors10.1016/j.ejmech.2018.07.073 ↗
11. Recent Insight into the Biological Activities of Synthetic Xanthone Derivatives10.1016/j.ejmech.2016.03.058 ↗
12. Antimicrobial Activity of Isoprenoid-Substituted Xanthones from Cudrania Cochinchinensis against Vancomycin-Resistant Enterococci10.1016/j.phymed.2004.03.010 ↗
13. Design, Synthesis and Activity against Staphylococcus Epidermidis of 5-Chloro-2- or 5-Chloro-4-Methyl-9H-Xanthen-9-One and Some of Its Derivatives
14. Preliminary Antifungal Activity Assay of Selected Chlorine-Containing Derivatives of Xanthone and Phenoxyethyl Amines10.1111/cbdd.13356 ↗
15. Glioblastoma Multiforme—An Overview
16. Survival Signalling and Apoptosis Resistance in Glioblastomas: Opportunities for Targeted Therapeutics10.1186/1476-4598-9-135 ↗
17. Desai, V., and Bhushan, A. (2017). Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme. Biomed Res. Int., 2017.10.1155/2017/9363040 ↗
18. Drug-like Properties and ADME of Xanthone Derivatives: The Antechamber of Clinical Trials10.2174/0929867323666160425113058 ↗
19. An Open-Labeled, Randomized, Multicenter Phase IIa Study of Gambogic Acid Injection for Advanced Malignant Tumors10.3760/cma.j.issn.0366-6999.20122582 ↗
20. Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel with or without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer10.1200/JCO.2011.35.0660 ↗
21. Xanthone Derivatives: New Insights in Biological Activities10.2174/092986705774370691 ↗
22. Milanović, D., Braun, F., Weber, W., Grosu, A.L., Behe, M., and Niedermann, G. (2012). The Influence of the Combined Treatment with Vadimezan (ASA404) and Taxol on the Growth of U251 Glioblastoma Xenografts. BMC Cancer, 12.10.1186/1471-2407-12-242 ↗
23. Synthesis of Xanthone Derivatives and Studies on the Inhibition against Cancer Cells Growth and Synergistic Combinations of Them10.1016/j.ejmech.2017.03.068 ↗
24. A New Short Synthesis of 5,6-Dimethylxanthenone-4-Acetic Acid (ASA404, DMXAA)10.1016/j.tetlet.2009.04.074 ↗
25. An Overview on Vadimezan (DMXAA): The Vascular Disrupting Agent10.1111/cbdd.13166 ↗
26. Disrupting Tumour Blood Vessels10.1038/nrc1628 ↗
27. Induction of Endothelial Cell Apoptosis by the Antivascular Agent 5,6-Dimethylxanthenone-4-Acetic Acid10.1038/sj.bjc.6600368 ↗
28. Efficacy against Subcutaneous or Intracranial Murine GL261 Gliomas in Relation to the Concentration of the Vascular-Disrupting Agent, 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA), in the Brain and Plasma10.1007/s00280-014-2395-y ↗
29. ASA404: Update on Drug Development10.1517/13543784.17.10.1547 ↗
30. Gambogic Acid Induces Apoptotic Cell Death in T98G Glioma Cells10.1016/j.bmcl.2015.11.043 ↗
31. Guidelines for Cell Viability Assays10.1002/fft2.44 ↗
32. Neutral Red Uptake Assay for the Estimation of Cell Viability/Cytotoxicity10.1038/nprot.2008.75 ↗
33. Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
34. An Improved Colorimetric Assay for Cell Proliferation and Viability Utilizing the Tetrazolium Salt XTT10.1016/0022-1759(91)90114-U ↗
35. Mind Your Assays: Misleading Cytotoxicity with the WST-1 Assay in the Presence of Manganese10.1371/journal.pone.0231634 ↗
36. A Water-Soluble Tetrazolium Salt Useful for Colorimetric Cell Viability Assay10.1039/a809656b ↗
37. Smith, S.M., Wunder, M.B., Norris, D.A., and Shellman, Y.G. (2011). A Simple Protocol for Using a LDH-Based Cytotoxicity Assay to Assess the Effects of Death and Growth Inhibition at the Same Time. PLoS ONE, 6.10.1371/journal.pone.0026908 ↗
38. Anticancer Activity of Mangosteen Pericarp Dry Extract Against Mcf-7 Breast Cancer Cell Line Through Estrogen Receptor -A10.14499/indonesianjpharm25iss3pp119 ↗
39. Anti-Cancer Effects of Xanthones from Pericarps of Mangosteen10.3390/ijms9030355 ↗
40. Biological Activities and Bioavailability of Mangosteen Xanthones: A Critical Review of the Current Evidence10.3390/nu5083163 ↗
41. Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs10.2174/156652411797536679 ↗
42. Kurniawan, Y.S., Tata, K., Priyangga, A., Pranowo, H.D., Sholikhah, E.N., Zulkarnain, A.K., Fatimi, H.A., and Julianus, J. (2021). An Update on the Anticancer Activity of Xanthone Derivatives: A Review. Pharmaceuticals, 14.10.3390/ph14111144 ↗
43. Preferential Target Is Mitochondria in α-Mangostin-Induced Apoptosis in Human Leukemia HL60 Cells10.1016/j.bmc.2004.08.034 ↗
44. Characterized Mechanism of α-Mangostin-Induced Cell Death: Caspase-Independent Apoptosis with Release of Endonuclease-G from Mitochondria and Increased MiR-143 Expression in Human Colorectal Cancer DLD-1 Cells10.1016/j.bmc.2007.04.071 ↗
45. Markowicz, J., Uram, Ł., Sobich, J., Mangiardi, L., Maj, P., and Rode, W. (2019). Antitumor and Anti-Nematode Activities of α-Mangostin. Eur. J. Pharmacol., 863.10.1016/j.ejphar.2019.172678 ↗
46. Zhang, H., Tan, Y.P., Zhao, L., Wang, L., Fu, N.J., Zheng, S.P., and Shen, X.F. (2020). Anticancer Activity of Dietary Xanthone α-Mangostin against Hepatocellular Carcinoma by Inhibition of STAT3 Signaling via Stabilization of SHP1. Cell Death Dis., 11.10.1038/s41419-020-2227-4 ↗
47. Apoptotic Effects of γ-Mangostin from the Fruit Hull of Garcinia Mangostana on Human Malignant Glioma Cells10.3390/molecules15128953 ↗
48. α-Mangostin, a Dietary Xanthone, Induces Autophagic Cell Death by Activating the AMP-Activated Protein Kinase Pathway in Glioblastoma Cells10.1021/jf1042757 ↗
49. Inhibition of Glioblastoma Growth and Angiogenesis by Gambogic Acid: An in Vitro and in Vivo Study10.1016/j.bcp.2007.10.033 ↗
50. Apoptosis Induction in Human Glioblastoma Multiforme T98G Cells upon Temozolomide and Quercetin Treatment10.1007/s13277-013-0785-0 ↗
51. A Unified Model for Apical Caspase Activation10.1016/S1097-2765(03)00051-0 ↗
52. Gambogic Acid Is a Novel Anti-Cancer Agent That Inhibits Cell Proliferation, Angiogenesis and Metastasis
53. A Role for Transferrin Receptor in Triggering Apoptosis When Targeted with Gambogic Acid10.1073/pnas.0406731102 ↗
54. Gambogic Acid Affects Ribosomal Occurrence in Glioma Cells by Downregulating the Phosphoinositide Kinase-3/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway10.1166/jnn.2020.17425 ↗
55. Gilani, S.A., Imran, M., Sciences, A., Haq, I.U., and Mehboob, R. (2020). Gambogic Acid as Anticancer Agent: A Review. Preprints, 2020070029.10.20944/preprints202007.0029.v1 ↗
56. Gambogic Acid as a Candidate for Cancer Therapy: A Review10.2147/IJN.S277645 ↗
57. Gartanin Induces Cell Cycle Arrest and Autophagy and Suppresses Migration Involving PI3K/Akt/MTOR and MAPK Signalling Pathway in Human Glioma Cells10.1111/jcmm.12937 ↗
58. Gartanin, an Isoprenylated Xanthone from the Mangosteen Fruit (Garcinia Mangostana), Is an Androgen Receptor Degradation Enhancer10.1002/mnfr.201600037 ↗
59. Bioactive Polyprenylated Benzophenone Derivatives from the Fruits Extracts of Garcinia Xanthochymus10.1016/j.bmcl.2017.06.073 ↗
60. Mangiferin Induces Radiosensitization in Glioblastoma Cells by Inhibiting Nonhomologous End Joining
61. Mangiferin Regulates Proliferation and Apoptosis in Glioma Cells by Induction of MicroRNA-15b and Inhibition of MMP-9 Expression10.3892/or.2015.3919 ↗
62. Molecular Mechanisms Underlying Mangiferin-Induced Apoptosis and Cell Cycle Arrest in A549 Human Lung Carcinoma Cells10.3892/mmr.2016.4947 ↗
63. Protective Role of Mangiferin against Benzo(a)Pyrene Induced Lung Carcinogenesis in Experimental Animals10.1248/bpb.31.1053 ↗
64. CML Cell Line K562 Cell Apoptosis Induced by Mangiferin]
65. Neves, A.R., Correia-da-Silva, M., Silva, P.M.A., Ribeiro, D., Sousa, E., Bousbaa, H., and Pinto, M. (2018). Synthesis of New Glycosylated Flavonoids with Inhibitory Activity on Cell Growth. Molecules, 23.10.3390/molecules23051093 ↗
66. Biological Activity, Quantitative Structure–Activity Relationship Analysis, and Molecular Docking of Xanthone Derivatives as Anticancer Drugs10.2147/DDDT.S149973 ↗
67. Alves, A., Correia-da-Silva, M., Nunes, C., Campos, J., Sousa, E., Silva, P.M.A., Bousbaa, H., Rodrigues, F., Ferreira, D., and Costa, P.C. (2019). Discovery of a New Xanthone against Glioma: Synthesis and Development of (Pro)Liposome Formulations. Molecules, 24.10.3390/molecules24030409 ↗
68. Cytotoxicity and Modes of Action of Three Naturally Occurring Xanthones (8-Hydroxycudraxanthone G, Morusignin i and Cudraxanthone I) against Sensitive and Multidrug-Resistant Cancer Cell Lines10.1016/j.phymed.2013.08.018 ↗
69. Xanthone-Rich Extract from Gentiana Dinarica Transformed Roots and Its Active Component Norswertianin Induce Autophagy and ROS-Dependent Differentiation of Human Glioblastoma Cell Line10.1016/j.phymed.2018.03.052 ↗
70. Lucanthone 86710.1021/jm00317a025 ↗
71. (2020, November 25). Safety and Efficiancy Study of Lucanthone When Used in Combination with Temozolomide (TMZ) and Radiation to Treat Glioblastoma Multiforme, Available online: https://clinicaltrials.gov/ct2/show/NCT01587144.
72. Naidu, M.D., Agarwal, R., Pena, L.A., Cunha, L., Mezei, M., Shen, M., Wilson, D.M., Liu, Y., Sanchez, Z., and Chaudhary, P. (2011). Lucanthone and Its Derivative Hycanthone Inhibit Apurinic Endonuclease-1 (APE1) by Direct Protein Binding. PLoS ONE, 6.10.1371/journal.pone.0023679 ↗
73. Inhibition of Cyclooxygenase and Prostaglandin E2 Synthesis by γ-Mangostin, a Xanthone Derivative in Mangosteen, in C6 Rat Glioma Cells10.1016/S0006-2952(01)00810-3 ↗
74. Gambogic Acid Induces EGFR Degradation and Akt/MTORC1 Inhibition through AMPK Dependent-LRIG1 Upregulation in Cultured U87 Glioma Cells10.1016/j.bbrc.2013.04.099 ↗